1. Home
  2. FCUV vs PPBT Comparison

FCUV vs PPBT Comparison

Compare FCUV & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCUV
  • PPBT
  • Stock Information
  • Founded
  • FCUV 2012
  • PPBT 2010
  • Country
  • FCUV United States
  • PPBT Israel
  • Employees
  • FCUV N/A
  • PPBT N/A
  • Industry
  • FCUV Industrial Machinery/Components
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCUV Industrials
  • PPBT Health Care
  • Exchange
  • FCUV Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • FCUV 31.5M
  • PPBT 5.5M
  • IPO Year
  • FCUV N/A
  • PPBT N/A
  • Fundamental
  • Price
  • FCUV $3.86
  • PPBT $0.75
  • Analyst Decision
  • FCUV
  • PPBT Strong Buy
  • Analyst Count
  • FCUV 0
  • PPBT 1
  • Target Price
  • FCUV N/A
  • PPBT $33.00
  • AVG Volume (30 Days)
  • FCUV 42.5K
  • PPBT 21.7M
  • Earning Date
  • FCUV 11-14-2025
  • PPBT 11-06-2025
  • Dividend Yield
  • FCUV N/A
  • PPBT N/A
  • EPS Growth
  • FCUV N/A
  • PPBT N/A
  • EPS
  • FCUV N/A
  • PPBT N/A
  • Revenue
  • FCUV $432,983.00
  • PPBT N/A
  • Revenue This Year
  • FCUV N/A
  • PPBT N/A
  • Revenue Next Year
  • FCUV N/A
  • PPBT N/A
  • P/E Ratio
  • FCUV N/A
  • PPBT N/A
  • Revenue Growth
  • FCUV 140.82
  • PPBT N/A
  • 52 Week Low
  • FCUV $1.80
  • PPBT $0.53
  • 52 Week High
  • FCUV $10.90
  • PPBT $13.95
  • Technical
  • Relative Strength Index (RSI)
  • FCUV 49.77
  • PPBT 47.82
  • Support Level
  • FCUV $3.80
  • PPBT $0.75
  • Resistance Level
  • FCUV $4.33
  • PPBT $0.91
  • Average True Range (ATR)
  • FCUV 0.35
  • PPBT 0.11
  • MACD
  • FCUV -0.09
  • PPBT 0.03
  • Stochastic Oscillator
  • FCUV 4.14
  • PPBT 20.59

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: